Reiner Susanne, Ziegler Nicole, Leon Catherine, Lorenz Kristina, von Hayn Kathrin, Gachet Christian, Lohse Martin J, Hoffmann Carsten
Department of Pharmacology and Toxicology, University of Wuerzburg, Versbacher Str. 9, 97078 Wuerzburg, Germany.
Mol Pharmacol. 2009 Dec;76(6):1162-71. doi: 10.1124/mol.109.060467. Epub 2009 Sep 9.
The nucleotide receptor P2Y(1) regulates a variety of physiological processes and is involved in platelet aggregation. Using human P2Y(1)-receptors C-terminally fused with a fluorescent protein, we studied the role of potential receptor phosphorylation sites in receptor internalization and beta-arrestin-2 translocation by means of confocal microscopy. Three receptor constructs were generated that lacked potential phosphorylation sites in the third intracellular loop, the proximal C terminus, or the distal C terminus. The corresponding receptor constructs were expressed in human embryonic kidney (HEK)-293 cells and stimulated with 100 muM ADP. Rapid receptor internalization was observed for the wild-type receptor and from those constructs mutated in the third intracellular loop and the proximal C terminus. However, the construct lacking phosphorylation sites at the distal C terminus did not show receptor internalization upon stimulation. The microscopic data were validated by HA-tagged receptor constructs using a cell surface enzyme-linked immunosorbent assay. P2Y(1)-receptor stimulated beta-arrestin-2-yellow fluorescent protein (YFP) translocation followed the same pattern as receptor internalization. Hence, no beta-arrestin-2-YFP translocation was observed when the distal C-terminal phosphorylation sites were mutated. Individual mutations indicate that residues Ser352 and Thr358 are essential for receptor internalization and beta-arrestin-2-YFP translocation. In contrast, protein kinase C (PKC)-mediated receptor desensitization was not affected by mutation of potential phosphorylation sites in the distal C terminus but was prevented by mutation of potential phosphorylation sites in the proximal C terminus. P2Y(1)-receptor internalization in HEK-293 cells was not blocked by inhibitors of PKC and calmodulin-dependent protein kinase. Thus, we conclude that P2Y(1)-receptor desensitization and internalization are mediated by different phosphorylation sites and kinases.
核苷酸受体P2Y(1)调节多种生理过程,并参与血小板聚集。我们利用与荧光蛋白C末端融合的人P2Y(1)受体,通过共聚焦显微镜研究了潜在受体磷酸化位点在受体内化和β -抑制蛋白2转位中的作用。构建了三种受体构建体,它们在第三个细胞内环、近端C末端或远端C末端缺少潜在的磷酸化位点。相应的受体构建体在人胚肾(HEK)-293细胞中表达,并用100 μM ADP刺激。观察到野生型受体以及在第三个细胞内环和近端C末端发生突变的构建体出现快速受体内化。然而,在远端C末端缺少磷酸化位点的构建体在刺激后未显示受体内化。使用细胞表面酶联免疫吸附测定法,通过带有HA标签的受体构建体验证了显微镜数据。P2Y(1)受体刺激的β -抑制蛋白2 -黄色荧光蛋白(YFP)转位与受体内化遵循相同模式。因此,当远端C末端磷酸化位点发生突变时,未观察到β -抑制蛋白2 - YFP转位。个别突变表明,Ser352和Thr358残基对于受体内化和β -抑制蛋白2 - YFP转位至关重要。相比之下,蛋白激酶C(PKC)介导的受体脱敏不受远端C末端潜在磷酸化位点突变的影响,但近端C末端潜在磷酸化位点突变可阻止其发生。HEK - 293细胞中的P2Y(1)受体内化不受PKC和钙调蛋白依赖性蛋白激酶抑制剂的阻断。因此,我们得出结论,P2Y(1)受体脱敏和内化由不同的磷酸化位点和激酶介导。